G protein-coupled receptors (GPCRs) turn extracellular signals into intracellular responses by activating heterotrimeric G proteins [1] [2] [3] . Upon binding an activating ligand, receptors catalyze the release of GDP bound to the Gα subunit. Subsequent binding of GTP causes dissociation of the Gα and Gβγ subunits from the receptor. A large number of mutagenesis studies have proposed the C-terminal helix α5 of Gα to be a key interaction site for receptor binding and a conduit for signal transduction [4] [5] [6] [7] [8] [9] . These data, in combination with crystal structures of individual G protein subunits and of trimetric G proteins have provided a broad understanding of the G protein activation mechanism 2,10-15 . More recently, the crystal structure of the β 2 adrenergic receptor-Gs complex (β 2 AR-Gs) 16 confirmed that the main site of interaction between the receptor and the G protein is the C terminus of helix α5 and also revealed additional contacts between intracellular loop 2 (ICL2) of the receptor and helix αN of the Gα s . The largest conformational change in the GTPase domain was a rotation of helix α5 and its displacement toward the receptor, accompanied by rearrangements of the α5-β6 interface, the phosphate-binding β1-α1 loop (P loop) and helix α1. This structure also showed the separation of the GTPase and helical domains of the G protein, in agreement with previous bioluminescence resonance energy transfer, double electron-electron resonance and single-particle electron microscopy data [17] [18] [19] . Furthermore, analysis of hydrogen/deuterium-exchange mass-spectrometry data 20 has led to the suggestion that G protein activation is also associated with increased disorder around the β1 strand and the nucleotide-binding pocket, especially at the P loop and the adjacent N-terminal part of helix α5, whereas the C terminus of Gα is protected upon binding the receptor.
a r t i c l e s G protein-coupled receptors (GPCRs) turn extracellular signals into intracellular responses by activating heterotrimeric G proteins [1] [2] [3] . Upon binding an activating ligand, receptors catalyze the release of GDP bound to the Gα subunit. Subsequent binding of GTP causes dissociation of the Gα and Gβγ subunits from the receptor. A large number of mutagenesis studies have proposed the C-terminal helix α5 of Gα to be a key interaction site for receptor binding and a conduit for signal transduction [4] [5] [6] [7] [8] [9] . These data, in combination with crystal structures of individual G protein subunits and of trimetric G proteins have provided a broad understanding of the G protein activation mechanism 2, [10] [11] [12] [13] [14] [15] . More recently, the crystal structure of the β 2 adrenergic receptor-Gs complex (β 2 AR-Gs) 16 confirmed that the main site of interaction between the receptor and the G protein is the C terminus of helix α5 and also revealed additional contacts between intracellular loop 2 (ICL2) of the receptor and helix αN of the Gα s . The largest conformational change in the GTPase domain was a rotation of helix α5 and its displacement toward the receptor, accompanied by rearrangements of the α5-β6 interface, the phosphate-binding β1-α1 loop (P loop) and helix α1. This structure also showed the separation of the GTPase and helical domains of the G protein, in agreement with previous bioluminescence resonance energy transfer, double electron-electron resonance and single-particle electron microscopy data [17] [18] [19] . Furthermore, analysis of hydrogen/deuterium-exchange mass-spectrometry data 20 has led to the suggestion that G protein activation is also associated with increased disorder around the β1 strand and the nucleotide-binding pocket, especially at the P loop and the adjacent N-terminal part of helix α5, whereas the C terminus of Gα is protected upon binding the receptor.
A recent modeling study 21 has suggested that G protein activation is associated with the rearrangement of the interfaces between helices α1 and α5, and between α5 and the α5-β6 loop. Subsequent experimental mutagenesis studies 22 pinpointed residue F336 in helix α5 of Gα i1 as being particularly important for G protein activation, because its mutation increases the rate of spontaneous GDP release. The proposed mechanism involves F336 acting as a relay transmitting conformational changes via strands β2, β3 and helix α1 to the phosphate-binding loop.
These combined data suggest a mechanism that involves binding of the C terminus of Gα to the receptor, accompanied by the formation of additional interactions between helix αN and the receptor, and subsequent transmission of the allosteric signal either via strand β1 or via a combination of strands β2 and β3 and helix α1 to destabilize the nucleotide-binding site. However, the exact details of the molecular mechanism of the activation remain unclear.
Here, we set out to establish a detailed and comprehensive understanding of the G protein activation mechanism at the residue level, to consolidate and extend existing knowledge. To do this, we characterized the influence of each amino acid of Gα i1 on the stability of the GDP-and GTP-bound states of Gα i1 alone, and the stability of the signaling complex between heterotrimeric G i (Gα i1 β 1 γ 1 ) and rhodopsin (Rho), a prototypical GPCR. The aggregated analysis of these data allowed us to draw a complete functional map of the Gα i1 subunit's stability at different stages of its activation cycle and to propose an activation mechanism at single-amino acid resolution.
RESULTS
We have recently shown that the complex between the heterotrimeric G i (Gα i1 β 1 γ 1 ) and rhodopsin (Rho) is more stable than the native Rho-G t complex and is suitable for biophysical studies 23 . In this work, we mutated each amino acid of Gα i1 to alanine or glycine and quantified (i) the thermal stability of each mutant in the inactive GDP-bound and the active GTP (GTPγS)-bound states and (ii) the efficiency of formation (relative abundance) and relative stability of the reconstituted Rho-G i protein complex (Figs. 1 and 2, Supplementary  Figs. 1-4, Supplementary Table 1 and Online Methods).
Interpretation of the changes in stability upon mutation Mutation of an amino acid to alanine (or to glycine, if the original amino acid is alanine) results in elimination of the side chain, thus leading to an alteration of the local structure that changes the stability of a protein or complex. If such a mutation has a large effect on protein stability, this suggests that the side chain is involved in many local interactions, indicating a structured environment. Conversely, a small change in stability implies that the side chain is not involved in many local interactions. Thus, if point mutations along a stretch of residues do not affect protein stability, the region is likely to be unstructured.
Importantly, changes in protein stability are sensitive to conformational rearrangements. This is the basis of phi-value analysis, a technique developed by Fersht and colleagues to study the energetic and structural details of protein-folding intermediates 24 . Here, we have adapted this method to study conformational changes of G i in the GTP-bound form and Rho*-G i (in which Rho* denotes the light-activated state of rhodopsin) complex relative to G i in the GDP-bound state, which we used as a reference state.
Comparison of the effects of mutations on stability for several conformational states of the protein substantially increases the interrogative power of the alanine-scanning technique. Importantly, this technique requires a wide coverage of the protein sequence, ideally with mutation of each single residue of the protein. Through integration of an exhaustive data set, we generated a detailed interpretation of the conformational changes during protein activation, which allowed us to expand, test or rule out existing hypotheses on the activation mechanisms of G proteins.
These simple considerations formed the basis for interpreting the measured stability changes in structural terms. For instance, we found that many mutations (30-50%) destabilize both GDP-bound Gα i1 and the Rho*-G i complex (Figs. 1 and 2 and Supplementary Table 1) . These mutated residues are located in regions with the same local environment (i.e., conformation) in both states and are thus important for the stability and integrity of the protein. However, mutations at several positions have different effects on GDP-bound Gα i1 and the Rho*-G i complex, thus indicating that they are in regions that undergo conformational changes upon formation of the complex. In this way, we identified positions that contribute specifically to the stability of Gα i1 in each conformation (Fig. 3) .
In order to compare and extrapolate our findings to other Gα proteins, throughout this paper we used the common G protein ∆T m (°C) Figure 1 Stability effects of Gα i1 alanine mutants on the nucleotide-bound and receptor-bound states. (a-c) Effects of alanine substitutions in Gα i1 on the stability of the GDP-(a), receptor-(b) and GTPγS-bound (c) states. In the GDP-and GTPγS-bound states (a,c), the change in melting temperature (∆T m ) for each single alanine mutant is mapped onto the crystal structure of GDP-bound Gα i1 (PDB 1GDD 11 ) and GTPγS-bound Gα i1 (PDB 1GIA 10 ), as a spectrum ranging from blue over white to red. In the receptor-bound state (b), the change in complex stability is mapped onto the homology model of the Rho*-G i complex (Online Methods) in colors ranging from blue over white to red. Rhodopsin is shown in orange. β and γ subunits are displayed in gray and green, respectively. GDP and GTPγS are shown as sticks. The GTPase domain of Gα i1 in the complex-bound state is shown in the same orientation as in the GDP-and GTP-bound states, whereas the helical domain is substantially displaced relative to the GTPase domain in the receptor-bound state. ) had a severe effect on the stability of the Rho*-G i complex, whereas mutation of the solvent-facing residues in this region did not have such an effect ( Fig. 1 and Supplementary Table 1) . Mutation R32A G.hns1.3 at the base of the N terminus stabilized the Rho*-G i complex, most probably by improving its interactions with ICL2 of the receptor. This stabilization effect is probably receptor specific because this position is not conserved in, e.g., Gs and thus may contribute to receptor-G protein specificity. It is also possible that this position interacts with the helical domain in its most 'open' conformation (as shown in Fig. 1b) .
Numerous studies have shown that the last 11 residues in the C terminus of Gα play a critical part in receptor binding 8, 9, 26, 27 . Accordingly, most alanine mutations at positions 344 G.H5.16 to 354 G.H5. 26 considerably affected the formation of the Rho*-G i complex (Figs. 1 and 4) . In particular, L348A G.H5.20 and L353A G.H5. 25 substitutions at conserved leucines and G352A G.H5.24 substitution at the less-conserved glycine at the end of the C terminus severely impaired coupling with the receptor without affecting the stability of the nucleotide-bound states. These data agree with NMR and crystallography studies on a G t C-terminal peptide bound to rhodopsin and with the crystal structure of the β 2 AR-G s complex, which showed that the C terminus of Gα s becomes helical and penetrates into a crevice formed at the cytoplasmic side of the transmembrane 
Rearrangement of activation cluster I upon complex formation
The movement of helix α5 in the GTPase domain upon formation of the G protein-receptor complex 4, 16, 21 has been reported to result in substantial conformational changes around its base, which is packed against the β-sheet consisting of strands β1-β6 and helix α1. Our data support such rearrangements, as shown by the different effects of mutations on the nucleotide-bound state and on the complex. Importantly, our analysis allowed us to focus on the contributions of individual amino acids to the stability of the different states of Gα i1 . We detected a number of residues with a concerted role for Gα i1 activation, which we termed activation cluster I (Figs. 3 and 5a), formed by several highly conserved hydrophobic residues from strands β1-β3, helix α1
and inward-facing residues of helix α5. Alanine substitutions of these residues considerably destabilized the GDP-bound conformation (3-18 °C) and moderately affected the GTPγS-bound state ( 
∆complex-formation efficiency (%) Figure 4 Effect on the nucleotide-bound and receptor-bound states of alanine mutants of the last 11 amino acids of Gα i1 . (a) Effect on the thermal stability of the GDP-bound and receptor-bound states of alanine mutants of the last 11 residues of the C terminus of Gα i1 . The CGN of the labeled residues is listed in Supplementary The involved residues are shown as spheres: light blue, destabilizing effect after mutation to alanine; white, stability comparable to that of wild type after mutation to alanine; light red, stabilizing effect after mutation to alanine. Residue labels are color coded as follows: orange, alanine mutations that dramatically destabilize the GDP-bound state but not the receptor-bound state; green, alanine mutations that do not affect the GDPbound state but substantially destabilize the receptor-bound state; black, alanine mutation that destablizes both GDP-and receptor-bound states. npg a r t i c l e s that resulted in substantial loss of Gα i1 stability and complete impairment of its ability to bind nucleotides. F336A G.H5.8 also caused protein aggregation and a severe impairment in the ability of Gα i1 to be reconstituted with Gβγ to form the Gαβγ heterotrimer (Supplementary Fig. 6 ). Interestingly, this mutant still formed a relatively stable complex with the receptor. In the structure of the β 2 AR-G s complex, the corresponding phenylalanine moved from the buried hydrophobic core of Gs α to contact ICL2 of the receptor 16 .
Our results suggest that F336 G.H5.8 has a critical role in stabilizing the Gα i1 subunit in the nucleotide-bound conformation, consistently with the observation that its mutation increases the rate of spontaneous nucleotide release 22 . We hypothesized that relocation of F336 G.H5.8 concomitant with the upward movement and twist of α5 triggers the reorganization of the cluster I into the receptor-bound state. Upon binding the receptor, a structural reorganization of cluster I disrupts the interactions that stabilize helix α1 (Fig. 5a) . This is suggested by our observations that mutations I49A G.H1.4 , M53A G.H1.8 and I56A G.H1.11 of α1; L38A G.S1.6 of β1; and T329A G.H5.1 and V332A G.H5. 4 of α5, which tether helix α1 in the Gα i1 -GDP state, severely impaired the stability of helix α1 but did not affect the stability of the Rho*-G i complex (Fig. 6a and Supplementary Table 1) . Moreover, mutations N331A G.H5.3 and V332A G.H5.4 of conserved residues in helix α5, which stabilizes the nucleotide-bound state by making connections to helix α1, increased the stability of the complex by 30% and 20%, respectively. Movement of these residues disrupted contacts between the base of helix α5 and helix α1 and of helix α1, which would lead to the loss of helicity at the base of helix α5, as observed in the β 2 AR-G s complex 16 . This order-to-disorder transition potentially increased the flexibility of the β6-α5 loop, which contains the guanine ring-binding TCAT motif, thus perturbing its interaction with GDP.
The loss of local structural stability associated with increased disorder in the C-terminal part of helix α1 and the N-terminal part of helix α5 is compensated by the strengthening of their interactions with the β4, β5 and β6 strands and the relocated helix α5. This is Orange squares, mutations that dramatically destabilize the GDP-bound state but do not affect the stability of the receptor-bound state; green squares, mutations that do not destabilize the GDP-bound state but substantially destabilize the receptor-bound state; black squares, mutations that destabilize both nucleotide-and receptor-bound states. The alanine mutants in orange and green correspond to the residue color coding in Figures 5a,b and 7a, Fig. 6 ). A sequence alignment of human G proteins showed that these residues are highly conserved in the Gα subfamily 25 . Together, these results indicate that these residues are not only important for stabilizing the G protein conformation in the receptor-bound state but also crucial for allosteric regulation of receptor-mediated G protein activation.
Y320 in activation cluster I as a signal-transduction hub
The Y320A G.S6.2 mutation in the β6 strand, which is a conserved tyrosine or phenylalanine in the Gα subfamily, severely impaired formation of the Rho*-G i complex (Figs. 5a and 6a ) but had only a moderate effect on the nucleotide-bound states. Remarkably, Y320A G.S6.2 , L348A G.H5.20 , G352A G.H5.24 and L353A G.H5.25 had a similarly strong effect on the formation of the complex, but Y320 G.S6.2 is the only position that does not interact directly with the receptor. In addition, Y320A G.S6.2 showed a well-preserved ability to bind nucleotides and form the heterotrimer (Supplementary Fig. 6 ). We hypothesized that the Y320A G.S6.2 mutation prevented the formation of an allosteric activation pathway that propagates the signal for GDP release transmitted from the receptor, thus making Y320 G.S6.2 a key signal-transduction hub in the mechanism of receptor-mediated G protein activation.
Cluster II is the structural scaffold of the GTPase domain
We identified a second cluster of residues with a common role in the GTPase domain formed by residues in helices α3, α4 and αG packed against residues in strands β4, β5 and β6 (Figs. 3 and 5b) . Whereas cluster II partially overlapped with cluster I, most mutations there destabilized both receptor-and nucleotide-bound states of Gα i1 . Most mutations destabilized the GDP-bound state by 3-13 °C, the receptor-bound state by 30-40% and the GTPγS-bound state by 1-5 °C (Figs. 5b and 6b) . Residues in cluster II are highly conserved among G proteins and probably form the structural scaffold of the Gα subunit 25 10 , which are located in solvent-exposed surface, also showed similar effects. We hypothesized that these residues may form additional stabilizing contacts in the receptor-bound conformation or may be involved in direct interactions with the receptor.
The helical domain behaves as a rigid body
A hallmark of G protein activation by the receptor is the release of GDP accompanied by the separation of the GTPase and helical domains. The helical domain consequently displays a dynamic equilibrium between multiple orientations relative to the GTPase domain 16, 18, 19, 30 . We showed that a cluster of mostly hydrophobic residues (63 H.HA.1 to 176 H.HF.6 ; stabilization cluster III) of Gα i1 stabilizes the helical domain (Figs. 3 and 7a and Supplementary Table 1) . In contrast to the mutations in the activation and stabilization clusters in the GTPase domain, most of which affected both the stability and formation of the Rho*-G i complex, mutations in stabilization cluster III did not affect the formation of the Rho*-G i complex (Figs. 6c  and 7a) . A sequence alignment shows that hydrophobic residues are conserved at these positions in all Gα subtypes (Supplementary Data Set 1). This is consistent with the observation that the helical domain can be expressed independently from the GTPase domain while retaining its ability to activate cGMP phosphodiesterase 31 . However, there were some exceptions. Mutations A138G H.HD.5 , L156A H.HE.6 , L159A H.HE.9 , R161A H.HE.11 and I162A H.HE.12 destabilized the Rho*-G i complex without affecting the stability of GDPand GTP-bound states (Figs. 6c and 7a, Supplementary Fig. 6 and Supplementary Table 1). Also, I78A H.HA. 16 reduced complex formation by 20%, and L175A H.HF.5 destabilized the GDP-bound state and reduced complex formation. These results suggest that subtle internal rearrangements of the helical domain are required to keep this domain's integrity in the Rho*-G i complex.
Weakening of the interdomain interface promotes activation
The interdomain interface in Gα i1 is composed of the N-terminal part of helices αA, αF, α1 and the αF-α1 loop (Fig. 3) . Mutation of the residues in this interface dramatically destabilized the GDP-bound state (5-14 °C) but did not destabilize the Rho*-G i complex. In fact, mutations K51A G.H1.6 , K54A G.H1.9 and I55A G.H1.10 increased the relative stability of the Rho*-G i complex by 15-20%. We also observed a similar effect for L175A H.HF.5 and R176A H.HF. 6 , which increased in GDP-bound and receptor-bound states. The involved residues are shown as spheres in both the GDP-bound and the receptor-bound states: light blue, destabilizing effect after mutation to alanine; white, stability comparable to that of wild type after mutation to alanine; light red, stabilization after mutation to alanine. Residue labels are color coded as follows: orange, alanine mutations that dramatically destabilize the GDP-bound state but not the receptor-bound state; green, alanine mutations that do not affect the GDP-bound state but substantially destabilize the receptor-bound state. npg a r t i c l e s complex stability by 9% and 17%, respectively (Figs. 6d and 7b and Supplementary Table 1) . A sequence alignment showed that the residues located in the interdomain interface of Gα i1 are highly conserved in all Gα subfamilies (Supplementary Data Set 1 and ref. 25 ). Our data suggest that subtle conformational perturbations in the interdomain interface of the GDP-bound state can facilitate the domain separation and the release of GDP, in agreement with previous observations that the helical domain dissociates from the GTPase domain upon binding to the receptor [16] [17] [18] . The importance of weakening the interdomain interface for G protein activation is further supported by the structure of the Gα subunit from Arabidopsis thaliana (AtGPA1) 32, 33 . This protein has a structure that is very similar to that of Gα i1 (r.m.s. deviation of 1.8 Å between backbone atoms). However, owing to the absence of classical GPCRs in plants, AtGPA1 exchanges nucleotides by a self-activation mechanism attributed to the marginally stable helical domain, which shows a tendency to dissociate from the GTPase domains and unfold. Comparison between the Gα i1 -GDP and AtGPA1 structures shows that they contain similar residues at the interdomain interface, whereas the cross-interface hydrogen bonds in AtGPA1 are weaker than those in Gα i1 -GDP (Supplementary Fig. 7) .
Differences between GDP-and GTP-bound states
The GTPγS-bound state of Gα i1 was more stable than the GDP-bound state. The apparent melting temperatures were, respectively, 70 °C and 63 °C at saturating concentrations of the corresponding nucleotides. In addition, GTPγS had a much higher affinity for Gα i1 compared with that of GDP, as judged by a steeper concentration dependence of the stabilizing effect (Supplementary Fig. 1 ). We observed that most mutations destabilized both GDP and GTPγS states, consistently with the relatively minor differences between the GDP-and GTPγS-bound crystallographic structures of Gα i1 (ref. 34) . One interesting observation is that the GTPγS-bound state was on average two-fold less sensitive to mutations (Supplementary Fig. 8 ), again suggesting that this is a more stable state. Also, several mutations concentrated around the third phosphate group and at the Gβγ interface had a disproportionally large effect on the GTPγS-bound state. This is precisely the area that undergoes conformational changes associated with the activation of the Gα, causing the dissociation of the α and βγ subunits.
DISCUSSION
The exhaustive coverage (the entire sequence of the Gα i1 subunit) and single-amino acid resolution of our mutagenesis analysis, combined with the stability measurements obtained for Gα i1 in its GDP-, receptor-and GTPγS-bound states, allowed us to obtain an extremely detailed data set to elucidate the molecular mechanisms of G protein activation. Our results showed that the interactions involved in the stabilization of the receptor-bound conformation of Gα i1 are broader and more complex than were previously suggested.
First, we identified two clusters of residues that confer stability to the GTPase domain. Activation cluster I consists of residues in helices α1 and α5 packed against residues in strands β1-β3 in the nucleotide-bound states. In the receptor-bound state, the interactions between α5-α1 and β1-β3 are weakened and are compensated for by a new set of interactions between α5 and strands β4-β6. The most prominent examples of residues involved in this rearrangement are Y320 G.S6.2 and H322 G.S6. 4 , which are crucial for the stabilization of the receptor-bound state but have no effect on the nucleotide bound state. Conversely, F336 G.H5.8 is important for the stability of the GDPand GTP-bound states but has little effect on the stabilization of the Rho*-G i complex. Helix α1 is likely to become mostly unstructured in the Rho*-G i complex, as judged by the absence of substantial effects of mutations on complex stability. However, some mutations toward the C terminus result in stabilization of the complex. Helix α1 is a recipient of the conformational changes that lead to the destabilization of the interdomain interface and to nucleotide release, a key step in G protein activation. Mutations in the interdomain interface between the GTPase and the helical domains, consisting of αA, αF, α1 and loop of αF-α1, dramatically destabilize nucleotide-bound states but either have no effect or stabilize the complex. The above-mentioned residues are just some of the most noticeable examples, but we found a network of residues that contribute to the stabilization of these distinct conformational states (Figs. 3, 5 and 7) .
In addition to being able to change its conformation, the G protein also has to maintain its structural integrity and identity during the signaling cycle. Stabilization cluster II includes residues in helices α3, α4 and αG that pack against residues in strands β4, β5 and β6. The majority of mutations in this cluster similarly affected both states, and we concluded that this cluster provides a steady structural scaffold Figure 8 Nucleotide exchange in the Gα i1 subunit mediated by the activation and stabilization clusters. Cluster I is colored in hot pink in both the GDP-and GTP-bound states (bottom), and in magenta in the receptor-bound state (top). Clusters II and III are colored in lemon yellow and cyan in the three states. The interdomain interaction and the interactions between helices α1 and α5 are shown as blue and gray bars, respectively. GDP and GTP are in dark blue. Cluster I consists of helices α1 and α5 packed against stands β1-β3 in the nucleotidebound states. In the receptor-bound state, these interactions are weakened and are compensated by new interactions between helix α5 and strands β4-β6. The most prominent examples of the residues involved in this rearrangement are Y320 G.S6.2 , which is crucial for the stabilization of the receptor-bound state, and F336 G.H5.8 , which is important for the stability of the GDPand GTP-bound states. Destabilization of helix α1 results in weakening of the interdomain interface, separation of the helical domain from the GTPase domain and release of GDP. npg a r t i c l e s to the GTPase domain. Because this cluster partially overlaps with activation cluster I, there were several mutations in strands β4-β6, such as I319 G.S6.1 , which primarily affected the receptor-bound state. A third cluster of residues maintains the structural integrity of the helical domain. Most mutations in this domain resulted in similar effects on the stability of the nucleotide-bound states or the Rho*-G i complex. Overall, these mutations were less detrimental to stability than mutations in the GTPase domain. Several mutations, mostly located in helix αH, destabilized the complex without affecting either the GDP-or the GTP-bound state, thus suggesting that this region undergoes some conformational changes upon receptor binding.
Recently, long-scale molecular dynamics simulations by Dror et al. 35 have suggested that the key events in G protein activation are structural rearrangements in the nucleotide-binding site, especially the repositioning of the β6-α5 loop, caused by the movement of helix α5 away from the nucleotide-binding site, and a concomitant weakening of the interdomain interface. They also found that the GDP could dissociate only if the helical domain was in the open conformation. Interestingly, the helical domain remains mostly rigid in the simulations. These findings are very complementary to our results.
Overall, our data suggest that the most consequential event in activation of Gα i1 is the destabilization of helix α1 caused by a rearrangement on activation cluster I. This leads to a perturbation and weakening of the interdomain interface, dissociation of the helical domain from the GTPase domain in a rigid-body movement and release of the GDP (Fig. 8) . How does the subsequent binding of GTP trigger dissociation of the complex? The answer may be found in the relative stability of the GDP-, GTP-and receptor bound states. The GTP-bound state of Gα i1 is thermodynamically the most stable state of the protein, as reflected by the considerably higher thermal stability of the GTPγS-bound state. Owing to GTP hydrolysis, the G protein is kinetically trapped in a less stable GDP-bound state. This is a metastable state because the nucleotide exchange rate is very low in the absence of the receptor, consistently with the proposed role of the helical domain to protect the GDP from exchange with GTP 13 readily available in the cytoplasm. As the complex is formed and the nucleotide-binding site becomes accessible, the additional stabilization by GTP overcomes the stability of the complex, leads to the stabilization of helix α1 and the interdomain interface and reverts helix α5 to its conformation in the nucleotide-bound state.
It is still an open question to what extent our findings can be generalized to other GPCR-G protein combinations and which aspects are specific to the Gα i1 or the Rho*-G i complex. However, in Flock et al. 25 , we have shown that many of the residues identified here may have similar roles in all G proteins.
METhODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METhODS
Alanine-scanning mutagenesis. The alanine-scanning expression library of Gα i1 was prepared as we have reported previously 36 . The wild-type (WT) plasmid was constructed by insertion of human G protein α subunit (Gαi1) into the pJ411 vector (DNA 2.0), which incorporated an N-terminal decahistidine tag followed by a TEV-cleavage site. The alanine mutants were produced by subjecting the WT plasmid to high-throughput (HTP) alanine mutagenesis, as we have reported previously 36 . All 354 amino acid residues in Gαi1 were mutated. All nonalanine residues were replaced with alanine, and alanine residues were replaced with glycine. The exact protein sequence of the construct is provided in the Supplementary Note. Preparation of native bg subunit (Gbg). Gβγ was separated from endogenous transducin (Gt) as previously described 23 . Briefly, dark-adapted bovine retinas (W L Lawson Company) were exposed to room light at 4 °C overnight. The rod outer segment (ROS) membranes were collected by centrifugation in a 25-30% (w/w) sucrose gradient. After isotonic and hypotonic washes, Gt was dissociated from ROS membranes by addition of GTP (Sigma-Aldrich). The collected Gt was filtered through a 0.22-µm membrane (Millipore) and dialyzed against dialysis buffer (10 mM Tris-HCl, pH 7.4, 2 mM MgCl 2 , and 1 mM DTT) containing 50% glycerol. Gβγ was further separated from the Gαt on a Blue-Sepharose column (GE Healthcare) by a linear salt gradient (0-500 mM NaCl) in dialysis buffer supplemented with 30% glycerol. Gβγ was concentrated to 1-5 mg/ml and stored at −80 °C.
Preparation of bovine rhodopsin. Bovine rhodopsin was extracted from dark-adapted ROS membranes prepared according to Okada's method 37 . The dark-adapted ROS membranes were solubilized in solubilization buffer (50 mM sodium acetate, pH 6, 1 mM EDTA, 2 mM 2-mercaptoethanol, 3 mM CaCl 2 , 3 mM MgCl 2 , 3 mM MnCl 2 , and 100 mM NaCl) supplemented with 80 mM (4.1%) β-dodecyl-d-n-maltoside (DDM) at 4 °C overnight. After centrifugation at 30,000 r.p.m. in a Ti70 rotor, the supernatant was diluted with solubilization buffer to a DDM concentration of 0.4%. The diluted sample was loaded onto a column packed with ConA Sepharose resin (GE Healthcare), which was equilibrated with washing buffer (solubilization buffer supplemented with 0.02% DDM). After extensive washing, bovine rhodopsin was eluted with solubilization buffer supplemented with 0.02% DDM and 0.2 M α-d-methylmannoside. The eluted bovine rhodopsin was concentrated to 1-4 mg/ml and stored at −80 °C.
High-throughput (HTP) culturing and purification of Ga i1 alanine mutants.
The recombinant Gαi1 alanine mutants were expressed in BL21(DE3) competent cells. The cultures were grown at 37 °C in TB medium (GERBU Biotechnik) in 24-well plates (one mutant/well) (Whatman UniFilter Microplates, GE Healthcare). The culture volume was 5 ml/well. When the OD 600 reached 0.6, cells were induced with 0.5 mM IPTG and allowed to continue to grow for 20 h at 20 °C. The cells were harvested by centrifugation, resuspended in binding buffer (25 mM Tris-HCl, pH 7.4, 500 mM NaCl, 10% glycerol, 50 mM imidazole, and 5 mM 2-mercaptoethanol) and transferred to a 96-deep well plate (Thermo Scientific). The resuspended cells were disrupted by sonication for 1 min with a SONICS VCX-600 sonicator equipped with an eight-pin probe. After cell lysates were clarified by centrifugation, the supernatants were loaded onto a deep 96-deep well filter plate (one mutant per well) preloaded with 500 µl cobalt chelating resin (GE Healthcare) and equilibrated with binding buffer. After extensive washing with binding buffer, the recombinant Gαi1 alanine mutants were eluted with elution buffer (25 mM Tris-HCl, pH 7.4, 500 mM NaCl, 10% glycerol, 500 mM imidazole, and 5 mM 2-mercaptoethanol). The eluted proteins were dialyzed against 25 mM HEPES, pH 7.4, 100 mM NaCl and 2 mM DTT with a Slide-A-Lyzer MINI Dialysis Device (Thermo Scientific). Among 354 alanine mutants, the purified R142A H.HD.9 , Y230A G.s4h3.4 , K270A G.s5hg.1 and D272A G.HG.2 mutants were severely aggregated and could not be used in further assays. The flowchart of HTP purification is shown in Supplementary Figure 1. Characterization of the effect of Ga i1 alanine mutants on the receptor-bound state by HTP assay. In each round, WT Gα i1 was always prepared in parallel with the Gα i1 alanine mutants (Gα i1 (Ala)) to form rhodopsin-G i protein complex (Rho*-G i (WT)) as the reference control. The recombinant Gα i1 alanine mutants (12.5 µM) from HTP purification and the native Gβγ t (10 µM) were reconstituted to form heterotrimers (G i ) by incubation in a 96-well PCR plate (one mutant per well) (Eppendorf) on ice for 2 h. Under the dim red light in the dark room, purified rhodopsin (18 µM) was added and mixed with G i in ice-cold assay buffer (25 mM HEPES, pH 7.4, 100 mM NaCl, 2 mM DTT, 0.02% DDM, 1 mM MgCl 2 , and 0.16 unit/ml apyrase). After irradiation with orange light (>495 nm) on ice for 10 min, the tetrameric Rho*-G i (Ala) complex was formed by coupling the activated rhodopsin with G i , and the formed Rho*-G i (Ala) complex was further incubated in the dark at 4 °C overnight. The reaction volume was 50 µl for each alanine mutant. 20 µl of each Rho*-G i (Ala) complex was transferred to another 96-well PCR plate and heated for 30 min in a PCR machine (Eppendorf Mastercycler Gradient) at 36.3 °C. After centrifugation at 3,000 r.p.m. for 10 min at 4 °C, 14 µl of formed Rho*-G i (Ala) complex (4 °C) and 14 µl of heated Rho*-G i (Ala) complex (36.3 °C) were mixed with NativePAGE Sample Buffer (4×) (Invitrogen) and NativePAGE 5% G-250 Sample Additive (Invitrogen), respectively. The mixtures were loaded onto 4-16% NativePAGE Bis-Tris-HCl gels (Invitrogen), and gel electrophoresis was performed in a 4 °C cold room according to the manufacturer's protocol. Protein markers were used with NativeMark Unstained Protein Standard (Invitrogen). The gel bands of the Rho*-G i complex were integrated and quantified with ImageJ software. The complex-formation efficiency (CF) (%) was obtained from normalization of the integrated density of the band of the Rho*-G i complex (ID C (Ala or WT), 4 °C) with the integrated density of that of the Rho*-G i (WT) complex (ID C (WT), 4 °C). The complex stability (CS) (%) was defined as the normalization of the integrated density of the band of the Rho*-G i complex (ID C (Ala or WT), 36.3 °C) with the that of the integrated density of the Rho*-G i (WT) complex (ID C (Ala or WT), 4 °C). The distribution and summary of ∆CF efficiency and ∆CS of each Gα i1 alanine mutant are listed in Figure 2 and Supplementary Table 1. The flowchart diagram of the HTP assay is shown in Supplementary Figure 2. HTP measurements of thermal stability of Ga i1 alanine mutants by differential scanning fluorimetry (DSF). The thermostability of each Gα i1 alanine mutant in the nucleotide-bound state was measured by HTP differential scanning fluorimetry (DSF). The samples were prepared on ice. 10 µl of recombinant Gα i1 alanine mutant stocks (0.7 µg/µl) was dispensed into a 96-well PCR plate (one mutant per well) (Eppendorf) and mixed with 100 µl ice-cold assay buffer (25 mM HEPES, pH 7.4, 100 mM NaCl, and 2 mM DTT) containing 5× SYPRO-orange (Invitrogen) and nucleotides (1 mM GDP or 100 µM GTPγS). After mixture, 110-µl reaction mixtures of each alanine mutant were divided into 0.2-ml PCR tubes (Qiagen) as three samples of 35 µl. The DSF experiments were performed with a Rotor GeneQ (Qiagen) by ramping from 25 °C to 95 °C at a rate of 3 °C/min. The melting temperature (T m ) was defined as the inflection point of the melting curve as analyzed by the Rotor Gene Q Series Software. The T m value of each Gα i1 alanine mutant (T m (Ala)) upon addition of the nucleotides was averaged from three individual experiments. The ∆T m value was defined as:
In each round, WT Gα i1 was always prepared in parallel with Gα i1 alanine mutants as a reference control. In addition, thermal-shift measurements for WT Gα i1 titrated with GDP and GTPγS were also performed with HTP DSF. 
